Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated clinical data from the
View interactive chart, options flow, and AI analysis for BEAM on Zorveq Finance.
Open BEAM Chart & Analysis →